Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules: a randomized, double-blind, non-inferiority clinical trial in Mexican infants.

Authors:
Macías-Parra M; Vidal-Vázquez P; Reyna-Figueroa J; Rodríguez-Weber MÁ; Moreno-Macías H and 4 more

Journal:
Front Public Health

Publication Year: 2024

DOI:
10.3389/fpubh.2024.1356932

PMCID:
PMC10920348

PMID:
38463163

Journal Information

Journal Title: Front Public Health

Detailed journal information not available.

Publication Details

Subject Category: Public, Environmental & Occupational Health

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest PV-V and MM-P have served as consultants to MSD México on unrelated topics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study received funding from Merck Sharp & Dohme Corp. (MSD Mexico). The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication."

Evidence found in paper:

"Clinical trial registration : ClinicalTrials.gov , NCT02193061."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025